Bennet, Cancer Survivors & Doctors in Denver Discuss Urgent Need to Ensure Medicare Beneficiaries Receive Coverage for Multi-Cancer Screening Tests


Download More Photos from the Roundtable HERE

Denver  ––  Today, Colorado U.S. Senator Michael Bennet hosted a roundtable discussion in Denver about his Medicare Multi-Cancer Early Detection Screening Coverage Act. During the discussion, local advocates –– including cancer survivors and doctors ––  stressed the need for this legislation to help detect cancer earlier, improve health, and reduce costs and loss of life. 

The bipartisan legislation that Bennet and U.S. Senator Mike Crapo (R-Idaho) reintroduced in May would provide Medicare coverage for multi-cancer screening tests to save lives and costs to the health care system. It would ensure Medicare beneficiaries have coverage for innovative tests that can detect multiple types of cancer before symptoms develop.

“Cancer is the second leading cause of death in the United States. I know from personal experience that early detection can make all the difference,” said Bennet. “This legislation will ensure that Medicare beneficiaries have access to the latest diagnostic technologies, which have enormous potential to save lives and costs to our health care system.”

“Screening for multiple cancers at one time could help detect more cancers at an early stage when they are more responsive to treatment.  This is particularly important in addressing health disparities," said RJ Ours, government relations director (CO & WY), American Cancer Society Cancer Action Network (ACS CAN). "We strongly support Senator Bennet's legislation and are working tirelessly to see that it passes the Congress this year." 

"Multi cancer early detection is a promising advance in the War on Cancer by opening the door to new tests for dozens of cancers," said Andi Dwyer, Director of the Colorado Cancer Screening Program at the University of Colorado Cancer Center.  "Senator Bennet, a cancer survivor himself, knows firsthand the life-saving benefits of early cancer screenings. His strong leadership offers a bright ray of hope for older Americans to have cancer detected at the earliest stages when treatments can be easier and far less costly."  

"Senator Bennet has earned the thanks of Colorado’s cancer community for his sponsorship of legislation to have Multi Cancer Early Detection tests covered by Medicare," said Christi Cahill, executive director of the Colorado Cancer Coalition. "We know the vast difference that early detection of cancer makes in the lives of patients, and we look forward  to working with the Senator and his team to ensure that this legislation becomes law in 2021." 

"As a survivor of multiple cancers, I’m proud to support Senator Bennet's efforts to provide affordable access to multi-cancer early detection because these tests could be the biggest step forward in decades for cancer patients here in Colorado and across the country," said Tommy Stewart, co-facilitator of the Denver Thyroid Cancer Support Group. "Early detection is a game-changer because if cancer is detected early, the five-year survival rate is nearly 90 percent. If cancer has already spread by the time it is diagnosed, that survival rate plummets to just 21 percent."

Congress has previously acted to provide Medicare coverage for other cancer screenings, including mammography and colorectal screenings. Under current law, Medicare only covers preventive services Congress has explicitly authorized, or the U.S. Preventive Services Task Force has recommended. The Multi-Cancer Early Detection Screening Coverage Act would:

  • Create authority for the Centers for Medicare and Medicaid Services (CMS) to cover the latest diagnostic technologies, once approved by the Food and Drug Administration (FDA), including blood-based multi-cancer early detection tests and future test methods that draw on samples of urine or hair;
  • Maintain CMS authority to use an evidence-based process to determine coverage parameters for these new tests; and
  • State that new diagnostic technologies will supplement, not replace, existing screenings and will not impact existing coverage and cost-sharing.

Without this legislation, it could take a decade after FDA approval for Medicare to cover new early detection technologies for cancer. To ensure timely, consistent coverage of screening items and services, the Multi-Cancer Early Detection Screening Coverage Act would establish a defined benefit category and reduce such delays, ensuring  the best health care decisions are available to patients. These new detection technologies will complement existing screenings and dramatically improve the country’s early detection capabilities for cancer.

The Multi-Cancer Early Detection Screening Coverage Act has the support of over 300 leading health care organizations across the United States, including: Chronic Care Collaborative, Colorado Cancer Coalition, Colorado BioScience Association, Colorado Gerontological Society, American Cancer Society Cancer Action Network (ACS CAN), Association of Community Cancer Centers, Cancer Support Community, Idaho Society of Clinical Oncology, National Alliance for Hispanic Health, National Minority Quality Forum (NMQF), Prevent Cancer Foundation, and Susan G. Komen®.

The bill text is available HERE.